Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2019 | Story Ruan Bruwer | Photo Ruan Bruwer
Braam van Wyk
Braam van Wyk, hockey high-performance manager at the University of the Free State, should gain valuable experience with the Ghana men’s hockey team.

Braam van Wyk, hockey high-performance manager at the University of the Free State (UFS), wants to plough back whatever he can at international level.

Van Wyk has been appointed as assistant coach of the Ghana men’s hockey team. It is only a part-time appointment, as they don’t play that many matches in a year. Ghana is ranked 35th in the world.  

He will assist the team in the run-up to the Africa Cup in August 2019, where they hope to perform well enough to get an opportunity to play in the Road to Tokyo qualifier for next year’s Olympic Games. 

Van Wyk currently coaches the Ghana players who are based in South Africa. 

“I see this as an opportunity to develop the players, but also for me as a coach to grow and to coach at international level. I am excited to try and add value. The plan is to implement it here at the UFS,” Van Wyk said.

He is also the head coach of the UFS men’s team since 2016, as well as the astro manager.

Learned a lot from coach dad

According to Van Wyk (32), who studied environmental management, he already started coaching in his first year of studies while he was still playing. He represented the UFS from 2006 to 2009. 

“Between 2010 and 2015, my focus shifted to umpiring and I officiated in 19 internationals of which five involved the Protea men’s team.” 

His father, also Braam, is never too far away for guidance. Braam Sr is an astute coach who stood at the helm of many teams over the years, including the Kovsie men and women. He also coached his son while he was playing for the UFS.

“While I was playing, I used to ask him a lot of questions. I learned so much from him and still approach him for advice. He has so much experience and has achieved so much.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept